Accurate Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$561K Buy
1,067
+65
+6% +$31.2K 0.05% 324
2026
Q1
$498K Buy
1,002
+126
+14% +$68.4K 0.06% 318
2025
Q4
$540K Buy
876
+33
+4% +$18.7K 0.07% 291
2025
Q3
$443K Buy
843
+54
+7% +$25.1K 0.06% 310
2025
Q2
$338K Buy
789
+106
+16% +$44.3K 0.05% 337
2025
Q1
$298K Sell
683
-25
-4% -$13.5K 0.06% 286
2024
Q4
$384K Buy
708
+13
+2% +$7.15K 0.07% 244
2024
Q3
$417K Buy
695
+149
+27% +$88.2K 0.08% 231
2024
Q2
$297K Sell
546
-10
-2% -$5.73K 0.07% 236
2024
Q1
$303K Buy
556
+29
+6% +$16.3K 0.09% 211
2023
Q4
$287K Sell
527
-26
-5% -$12.6K 0.09% 203
2023
Q3
$268K Buy
553
+33
+6% +$17.6K 0.08% 203
2023
Q2
$275K Buy
+520
New +$281K 0.09% 209
2023
Q1
Sell
-697
Closed -$396K 1339
2022
Q4
$396K Buy
+697
New +$369K 0.15% 124

Other funds holding TMO

Accurate Wealth Management's TMO Position: Q2 2026 in Review

Accurate Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 6.5% in Q2 2026, buying an estimated $31.2K and bringing the position to 1,067 shares worth $561K. The position accounts for 0.05% of the portfolio, ranked #324.

Accurate Wealth Management first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. 953 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Accurate Wealth Management held 1,067 shares of Thermo Fisher Scientific worth $561K as of Q2 2026.
  • Accurate Wealth Management bought 65 Thermo Fisher Scientific shares in Q2 2026, an estimated $31.2K.
  • Thermo Fisher Scientific made up 0.05% of Accurate Wealth Management's portfolio in Q2 2026, its #324 holding.
  • Accurate Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • 953 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.